Suppr超能文献

喹硫平:尽管对多巴胺-2受体的阻断作用只是短暂性的高度阻断,但它仍是首发精神分裂症的一种有效抗精神病药物。

Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.

作者信息

Tauscher-Wisniewski Sitra, Kapur Shitij, Tauscher Johannes, Jones Corey, Daskalakis Zafiris J, Papatheodorou George, Epstein Irvin, Christensen Bruce K, Zipursky Robert B

机构信息

Schizophrenia and Continuing Care Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Canada.

出版信息

J Clin Psychiatry. 2002 Nov;63(11):992-7. doi: 10.4088/jcp.v63n1106.

Abstract

BACKGROUND

It has been suggested that transiently high dopamine-2 (D(2)) receptor occupancy by antipsychotic medication may be sufficient for inducing an antipsychotic response. We treated patients experiencing their first episode of schizophrenia with a single daily dose of quetiapine to achieve a transient daily peak of D(2) receptor blockade, to determine if this would lead to an antipsychotic response.

METHOD

Fourteen patients with a DSM-IV diagnosis of schizophrenia or schizophreniform or schizoaffective disorder were treated with quetiapine titrated to a single daily dose (mean +/- SD dose at the time of the positron emission tomography [PET] scan = 427 +/- 69 mg) for 12 weeks. Peak D(2) occupancy approximately 2 hours postdose and trough D(2) occupancy approximately 20 hours postdose were determined using PET and [(11)C]raclopride. Clinical symptoms and side effects were measured at baseline and every 2 weeks during the treatment phase.

RESULTS

Quetiapine administration led to a mean peak D(2) occupancy of 62% +/- 10% 2 hours postdose, which declined to 14% +/- 8% approximately 20 hours postdose. Ten (71%) of 14 patients responded to treatment with quetiapine, scoring "much improved" or greater on the Clinical Global Impressions-Improvement scale. Plasma drug levels and peak D(2) occupancy were highly correlated (r = 0.84; p =.003), as were prolactin and plasma drug levels when measured 2.5 hours after drug administration (r = 0.60; p <.05). Mean weight gain for the 10 subjects who completed the 12-week study was 4.2 +/- 4.6 kg (9.3 +/- 10.2 lb). No clinically relevant motor side effects occurred during the trial.

CONCLUSION

Patients with a first episode of schizophrenia responded to treatment with a single daily dose of quetiapine despite only transiently high D(2) receptor occupancy. Our findings raise the question of whether continuously high D(2) blockade is necessary for obtaining an antipsychotic response. Future studies aimed at evaluating the relative merits of "transiently high" versus "continuously high" D(2) occupancy are warranted.

摘要

背景

有观点认为,抗精神病药物引起的多巴胺-2(D₂)受体短暂性高占有率可能足以引发抗精神病反应。我们给予首次发作的精神分裂症患者每日单次剂量的喹硫平,以实现D₂受体阻断的每日短暂峰值,从而确定这是否会导致抗精神病反应。

方法

14例符合DSM-IV精神分裂症、分裂样或分裂情感性障碍诊断标准的患者接受喹硫平治疗,滴定至每日单次剂量(正电子发射断层扫描[PET]扫描时的平均±标准差剂量 = 427 ± 69 mg),为期12周。使用PET和[¹¹C]雷氯必利测定给药后约2小时的D₂占有率峰值以及给药后约20小时的D₂占有率谷值。在治疗阶段,于基线及每2周测量临床症状和副作用。

结果

服用喹硫平后,给药后2小时的D₂占有率峰值平均为62% ± 10%,给药后约20小时降至14% ± 8%。14例患者中有10例(71%)对喹硫平治疗有反应,在临床总体印象改善量表上评分“明显改善”或更高。血浆药物水平与D₂占有率峰值高度相关(r = 0.84;p = 0.003),给药后2.5小时测量的催乳素与血浆药物水平也高度相关(r = 0.60;p < 0.05)。完成12周研究的10名受试者的平均体重增加为4.2 ± 4.6 kg(9.3 ± 10.2磅)。试验期间未出现临床相关的运动副作用。

结论

首次发作的精神分裂症患者对每日单次剂量的喹硫平治疗有反应,尽管D₂受体占有率仅短暂升高。我们的研究结果提出了一个问题,即持续高D₂阻断对于获得抗精神病反应是否必要。未来有必要开展研究,评估“短暂性高”与“持续性高”D₂占有率的相对优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验